This research uses artificial intelligence to analyse immune-system data and predict vaccine effectiveness. By identifying early biological signals associated with strong, long-lasting immunity, the work aims to improve vaccine design, personalise vaccination strategies, and support development of universal vaccines capable of protecting against rapidly evolving infectious diseases.

This research develops a model to identify unreliable or manipulated environmental, social, and governance (ESG) claims made by South African companies. Using prior studies and a large ESG database, the model detects authenticity, flags potential manipulation, and cross-checks with known scandals. The goal is to measure genuine ESG commitment and protect stakeholders from misleading sustainability reporting.